Delivery Order SPE2DB20D3101-SPE2DB23FRVR1
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Prevacid 15 mg Solutab tablets. The $25,754.55 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through March 2022. The contract does not have a set-aside designation, indicating the competition was open. AmerisourceBergen is a major pharmaceutical distributor that holds significant Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 100 unit doses of 30 mg Prevacid (lansoprazole) delayed-release solutab. The contract has a ceiling value of $33,417.14 and is a firm fixed-price delivery order with a completion date of November 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of PREVACID DR 30 MG SOLUTAB UD 100S, a pharmaceutical product, with a ceiling value of $1,844.12. The contract is a delivery order and is priced on a firm fixed price basis. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Prevacid DR 30 mg Solutab (100 count). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,360.65. It has an ultimate completion date of February 3, 2025 and was awarded on January 31, 2025. The contract is not set aside for any specific business type. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that...
- The Defense Logistics Agency awarded a delivery order valued at $14,610.88 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Prevacid DR 30 mg Solutab unit dose tablets (100 count). This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $5,653.68 firm fixed price contract is for the supply of Prevacid DR 30 mg Solutab medication to the Defense Logistics Agency (DLA), a defense agency. The contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,360.56 for Prevacid DR 30 mg Solutab UD in quantities of 100 tablets. This firm fixed-price delivery order, executed on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal...
- The Defense Logistics Agency has awarded a delivery order valued at $2,080.53 to AmerisourceBergen Drug Corp for the supply of Prevacid DR 15 mg Solutab UD in quantities of 100 units. This firm fixed price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order...
- The Defense Logistics Agency awarded a delivery order valued at $1,087.58 to AmerisourceBergen Drug Corp for Prevacid DR 15 mg SoluTab unit dose tablets (100-count package). This firm fixed-price delivery order, issued on December 30, 2025, with completion by December 31, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Prevacid DR 15 mg Solutab medication, with a ceiling value of $1,025.52 and a period of performance through May 2, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRVR1Delivery Order
This federal contract award is for the delivery of Prevacid 30mg solutab tablets to the Defense Logistics Agency (DLA). The $11,992.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 23, 2023. The contract has an ultimate completion date of August 24, 2023 and is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 8/23/23 |